InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 16.10
-0.10 (-0.62%)
Jan 22, 2026, 2:02 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.74 billion as of January 22, 2026. Its market cap has decreased by -5.54% in one year.
Market Cap
1.74B
Enterprise Value
1.52B
Revenue
55.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.10
Market Cap Chart
Since September 13, 2012, InnoPharmax's market cap has increased from 1.54B to 1.74B, an increase of 13.04%. That is a compound annual growth rate of 0.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.74B | -3.57% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 215.25B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.72B |
| Bora Pharmaceuticals Co., LTD. | 64.74B |
| Oneness Biotech | 33.97B |
| Center Laboratories | 31.09B |
| Lin BioScience | 30.77B |